Increased Interleukin-8 (IL8)-CXCR2 Signaling Promotes Progression of Bone Marrow Fibrosis in Myeloproliferative Neoplasms

Andrew Dunbar(Memorial Sloan Kettering Cancer Center), Ronald Hoffman(Icahn School of Medicine at Mount Sinai), Julie L. Yang(Memorial Sloan Kettering Cancer Center), Aishwarya Krishnan(Memorial Sloan Kettering Cancer Center), Ross L. Levine(Memorial Sloan Kettering Cancer Center), Mirko Farina(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Mohamed E. Salama(The University of Texas at San Antonio Health Science Center), Jenna Snyder(Memorial Sloan Kettering Cancer Center), Richard P. Koche(Massachusetts General Hospital), Abdul Karzai(Memorial Sloan Kettering Cancer Center), Dongjoo Kim(Yale University), Young Joo Park(Sutro Biopharma (United States)), Min Lü(Central South University), Rong Fan(Yale Cancer Center)
Blood
November 5, 2020
10.1182/blood-2020-138843
Cited by 5

Related Papers

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Genome-wide maps of chromatin state in pluripotent and lineage-committed cells
|Nature|2007|4.2k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k